Major indices were in the green earlier on Wednesday as traders digested more bank earnings and another key inflation report.

Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.

On the other side, on July 7, JP Morgan analyst Chris Schott reiterated a Buy rating on Regeneron, while maintaining his $800 ...

Detailed price information for Starbucks Corp (SBUX-Q) from The Globe and Mail including charting and trades.

JPMorgan initiated coverage of Circle stock with an underweight rating and $80 price target, citing competition and regulation as key risks to growth.

Apple’s stock took a minor confidence hit today, as JPMorgan lowered its price target, though the firm kept its overall rating intact.

Regeneron holds an average rating of “Moderate Buy,” with 20 analysts still recommending it as a solid pick and three even going all-in with “strong buy” ratings. With the average price target now at ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the 13 Biotech Stocks with Huge Upside Potential. JPMorgan has maintained its Overweight rating on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) ...

Regeneron Pharmaceuticals faced a round of target cuts from major financial institutions, with JPMorgan Chase & Co. leading the charge by lowering its price objective from $950 to $800. Despite the ...

Acadia wins Nuplazid patent case, extending protection to 2038, as JP Morgan boosts price target ahead of key appeal on the ‘740 COM patent.

Pinterest shares rose in premarket trading Tuesday after JPMorgan analysts upgraded their rating and lifted their price target on the social media stock.